Matches in Wikidata for { <http://www.wikidata.org/entity/Q100380374> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q100380374 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q100380374 description "scientific article published on 29 September 2020" @default.
- Q100380374 description "wetenschappelijk artikel" @default.
- Q100380374 description "наукова стаття, опублікована 29 вересня 2020" @default.
- Q100380374 name "Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors" @default.
- Q100380374 name "Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors" @default.
- Q100380374 type Item @default.
- Q100380374 label "Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors" @default.
- Q100380374 label "Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors" @default.
- Q100380374 prefLabel "Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors" @default.
- Q100380374 prefLabel "Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors" @default.
- Q100380374 P1433 Q100380374-581BAD67-77C8-4533-B080-CBB45F924A8B @default.
- Q100380374 P1476 Q100380374-773701A9-D8EB-467A-88A3-9C2D745C48B0 @default.
- Q100380374 P2093 Q100380374-57EFE4F7-54B2-4941-8859-7BE75FCCA14A @default.
- Q100380374 P2093 Q100380374-A336E54E-76F8-4209-85CB-75584ECF7DFE @default.
- Q100380374 P31 Q100380374-85D83E88-B737-4831-B9F8-834F65B275E5 @default.
- Q100380374 P356 Q100380374-A7D767C3-2A97-4EEC-85D5-AB6DF422C3BD @default.
- Q100380374 P50 Q100380374-DBF9E2A1-C9F1-4111-8675-B0ECFAA147C9 @default.
- Q100380374 P577 Q100380374-D0D3D1A1-1841-49B7-BAA3-F4054D0660E3 @default.
- Q100380374 P698 Q100380374-CAED2938-5396-4BB4-83CE-81A5702AF587 @default.
- Q100380374 P921 Q100380374-DD750F3C-848B-4B19-A207-862467AB23ED @default.
- Q100380374 P356 ACS.BIOCONJCHEM.0C00496 @default.
- Q100380374 P698 32991164 @default.
- Q100380374 P1433 Q2343023 @default.
- Q100380374 P1476 "Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors" @default.
- Q100380374 P2093 "Chunhua Yin" @default.
- Q100380374 P2093 "Fei Kong" @default.
- Q100380374 P31 Q13442814 @default.
- Q100380374 P356 "10.1021/ACS.BIOCONJCHEM.0C00496" @default.
- Q100380374 P50 Q100380372 @default.
- Q100380374 P577 "2020-09-29T00:00:00Z" @default.
- Q100380374 P698 "32991164" @default.
- Q100380374 P921 Q18936 @default.